Tag: hypertriglyceridemia

March 16, 2018

Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Gemphire Therapeutics (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia, non-alcoholic fatty...
February 14, 2018

Acasti Pharma Reports Third Quarter FY 2018 Financial Results

Acasti Pharma (NASDAQ:ACST) a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3...
January 22, 2018

Acasti Pharma Announces the Closing of Over-Allotment Option for its Public Offering of Common Shares

Acasti Pharma (NASDAQ:ACST) a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® for...
January 18, 2018

Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China

Amarin (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics, announced that a clinical trial of Vascepa® (icosapent ethyl) capsules in...
January 11, 2018

Biotech Showcase Conference: Notes from the Floor, Day Three

INN brings the latest from the last day of the Biotech Showcase conference in San Francisco.
January 8, 2018

Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures

Acasti Pharma (NASDAQ:ACST; TSXV:ACST) has announced that in accordance with the terms of the outstanding convertible debentures in the total...
November 8, 2017

Acasti Pharma Gets Principal Investigator for CaPre Phase 3 Program

Acasti Pharma announced Dr. Dariush Mozaffarian will serve as the principal investigator to oversee the phase 3 development program of...